Archives
Why CSN2 Targeting Raises Rabbit Pharming Yields
2026-11-18
A mechanistic interpretation of how endogenous CSN2 regulatory control may increase recombinant protein concentration in rabbit milk, and why the reported tdTomato result does not yet establish general therapeutic manufacturing performance.
How a Rabbit Milk Locus Raised Pharming Yield
2026-11-17
A literature-focused analysis of how targeted insertion at the rabbit CSN2 locus was linked to higher recombinant-protein concentrations, what the study demonstrated, and which questions remain unresolved.
Context Determines What a Yield Result Means
2026-11-17
A high concentration can be an important discovery without proving broad production performance. The rabbit pharming study illustrates how promoter choice, genetic locus, animal genotype, reporter identity and measurement context determine what a reported result can support—and why that result should not be attributed to HEPES or to pH buffering.
Cy3 Maleimide and the Evidence for H1 Repair
2026-11-16
The reported study connects phosphorylated linker histone H1 with replication-stress repair through ssDNA association, HPF1 engagement, and cellular rescue phenotypes. Cy3 maleimide is best interpreted as a thiol-reactive fluorescent measurement reagent: useful for making labeled biomolecules visible, but not evidence by itself for binding, repair activity, or causality.
When Context Changes an NHE1 Result
2026-11-16
Atherosclerosis findings become more informative when plaque pathology, macrophage assays, pathway perturbations and immunoblot measurements are interpreted as different layers of evidence. The associated secondary-antibody detection material supports measurement, but does not itself establish NHE1 causality.
What CMC Reveals About mRNA–LNP Translation
2026-11-15
A literature-focused analysis of how lipid chemistry, manufacturing control, analytical characterization, and comparability shape the translation of mRNA lipid nanoparticles.
A Targeted Route to Higher Rabbit Pharming Yields
2026-11-14
A 2025 study tested whether placing a reporter transgene at the rabbit CSN2 milk-protein locus could raise recombinant protein concentrations in milk. The reported 15–20 g/L output in two homozygous animals is striking, but its interpretation is bounded by the small animal sample, cross-study comparisons, and the use of tdTomato rather than a therapeutic protein.
How CMC Shapes mRNA-LNP Translation
2026-11-13
A 2026 review explains why mRNA–lipid nanoparticle translation depends on more than delivery potency: lipid chemistry, particle attributes, physiological stability, analytical control, manufacturing comparability and regulatory precedent must be interpreted as one connected evidence chain.
Rabbit Pharming Through Targeted CSN2 Expression
2026-11-13
A literature-focused analysis of a 2025 rabbit pharming study shows how targeted insertion at the endogenous CSN2 locus produced heritable tdTomato expression and reported milk concentrations of 15–20 g/L in two homozygous females. The result is a promising proof of concept, but its interpretation is bounded by the reporter model, small animal number, historical rather than direct comparators, and the difference between concentration and total production.
What LNP Comparisons Really Establish for mRNA
2026-11-12
A source-grounded analysis of how lipid chemistry, carrier class, manufacturing strategy, and analytical controls shape interpretation of mRNA delivery evidence—and where published comparisons remain insufficient.
Why CSN2 Targeting Matters in Rabbit Pharming
2026-11-12
A 2025 study tested whether placing a reporter gene at the rabbit CSN2 milk-protein locus could overcome the variability of conventional transgenic pharming. The reported 15–20 g/L milk concentration in two homozygous animals is striking, but its broader significance is limited by the reporter construct, small production cohort, and lack of a controlled comparison with conventional lines.
How LNP Chemistry Shapes mRNA Translation
2026-11-11
A mechanistic interpretation of how lipid chemistry, particle attributes, and manufacturing controls influence the translation of mRNA delivery systems.
When Context Changes What a Result Means
2026-11-11
A result is not separable from the model, perturbation, readout and material context that produced it. Research on CCR7–Notch1 signaling in mammary cancer illustrates how genetic, pharmacological, cellular and database evidence support different levels of inference—and why heparin-affinity purification should not be mistaken for functional validation.
How LNP Chemistry Shapes mRNA Translation
2026-11-10
An evidence-led analysis of how lipid chemistry, particle attributes, manufacturing control, and physiological stability interact in mRNA delivery—and why these measurements should not be treated as interchangeable evidence of clinical performance.
How CSN2 Targeting Raised Rabbit Pharming Yields
2026-11-10
A 2025 study tested whether placing a reporter transgene at the endogenous CSN2 milk-protein locus could improve recombinant protein production in rabbits. Its high milk concentration is a compelling feasibility result, but the evidence remains limited by the reporter context, small number of high-yield animals, and the absence of a direct, controlled comparison isolating each design feature.